Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Non-cash Items: 2017-2024

Historic Non-cash Items for UroGen Pharma (URGN) over the last 8 years, with Dec 2024 value amounting to $2.1 million.

  • UroGen Pharma's Non-cash Items fell 60.01% to $2.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.1 million, marking a year-over-year decrease of 60.01%. This contributed to the annual value of $2.1 million for FY2024, which is 12.02% up from last year.
  • Latest data reveals that UroGen Pharma reported Non-cash Items of $2.1 million as of FY2024, which was up 12.02% from $1.8 million recorded in FY2023.
  • In the past 5 years, UroGen Pharma's Non-cash Items ranged from a high of $13.5 million in FY2020 and a low of $1.8 million during FY2023.
  • In the last 3 years, UroGen Pharma's Non-cash Items had a median value of $1.9 million in 2022 and averaged $1.9 million.
  • Per our database at Business Quant, UroGen Pharma's Non-cash Items plummeted by 84.08% in 2021 and then increased by 12.02% in 2024.
  • UroGen Pharma's Non-cash Items (Yearly) stood at $13.5 million in 2020, then slumped by 84.08% to $2.1 million in 2021, then declined by 11.15% to $1.9 million in 2022, then fell by 4.10% to $1.8 million in 2023, then rose by 12.02% to $2.1 million in 2024.